10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Fulgent Genetics Inc. (FLGT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 1,270,649 | $27,611,203 | +33% | 0.01% |
| 2. | Park West Asset Management Peter S. Park | 713,584 | $15,506,180 | -15% | 1.1% |
| 3. | Citadel Investment Group Ken Griffin | 302,918 | $6,582,408 | +63% | 0% |
| 4. | Point72 Asset Management Steve Cohen | 269,375 | $5,853,510 | 0.01% | |
| 5. | Invenomic Capital Management Ali Motamed | 249,747 | $5,427,002 | +99% | 0.29% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.95 | 8,739 | Large Shareholder, Officer, Director | 6,579,326 | 2019-03-05 | Filing | |
| $3.59 | 10,880 | Large Shareholder, Officer, Director | 6,570,587 | 2018-11-13 | Filing | |
| $3.36 | 10,000 | Large Shareholder, Officer, Director | 6,559,707 | 2018-11-09 | Filing | |
| $3.60 | 1,000 | Large Shareholder, Officer, Director | 1,000 | 2017-11-30 | Filing | |
| $3.60 | 1,000 | Large Shareholder, Officer, Director | 1,000 | 2017-11-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.50 | 1,455 | 334,681 | 2024-12-03 | Filing | ||
| $19.50 | 1,373 | 919,469 | 2024-12-03 | Filing | ||
| $18.26 | 2,227 | 703,711 | 2024-11-25 | Filing | ||
| $18.26 | 497 | 920,842 | 2024-11-25 | Filing | ||
| $18.26 | 689 | 336,136 | 2024-11-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,761,878 | $108,755,893 | 0% | |
| 2. | 1,447,153 | $41,838,725 | 0.01% | |
| 3. | 1,416,191 | $40,942,082 | 0% | |
| 4. | 1,000,000 | $28,910,000 | 0% | |
| 5. | 812,932 | $23,501,864 | 0% |
News See All
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Fulgent Genetics Q3 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2024 Earnings Call Transcript
Operator: Hello and welcome to the Fulgent Genetics Q2 2024 Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript
Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.33. Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript
Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $0.28, expectations were $-0.3. Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Fulgent Genetics Q3 2023 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2023 Earnings Call Transcript
Operator: Hello and welcome to the Fulgent Genetics Q2 2023 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
10 DNA Stocks Billionaires Are Loading Up On
Genomics is the study of a complete set of DNA within an organism.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2023 Earnings Call Transcript
Operator: Hello and welcome to the Fulgent Genetics Q1 2023 Earnings Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Billionaire Hedge Funds
